Shopping Cart 0
Cart Subtotal
USD 0

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd (YRDC), a subsidiary of Hebrew University of Jerusalem, is a technology transfer company. The company offers marketing and licensing the inventions, products, and technologies developed by the university's faculty, staff, researchers, and students. Its products include exelon, doxil, cherry tomatoes and long shelf-life tomatoes, granagard, osmoter x6 facial serum, hybrid peppers, hygia nutrients, artichoke, cationorm, agcite, vuze, melon, periochip, ikervis, explora, superior ceramic ink, uv-pearl, seer, and bioresorbable adhesion barrier. YRDC transfers the technologies in various fields including computer science, medicine and pharmaceuticals, nanotechnology, water and environmental technologies, agriculture and nutrition, homeland security, and others. The company supports business partners in identifying the researcher to conduct the research and tailor the partnerships to the requirements of the business partner and the technologies. YRDC is headquartered in Jerusalem, Israel.

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deal Details 14

Venture Financing 14

Atox Bio Raises USD30 Million in Financing 14

Avraham Pharma Raises up to USD4.5 Million Financing 16

Avraham Pharma Raises USD4.5 Million in Venture Financing 17

Avraham Pharma Raises USD 6 Million In Venture Financing 19

Integra Holdings Raises USD 7 Million In First Round Financing 20

Partnerships 21

Phytecs Enters into Agreement with Yissum Research Development 21

Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 22

Accurexa Enters into Agreement with Yissum Research Development 23

Yissum Research Development Expands Licensing Agreement with Israel Chemicals 24

Licensing Agreements 25

BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25

Spherium Biomed Enters into Option Agreement with Yissum 26

Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 27

BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 28

Immune Pharma Enters into Licensing Agreement with Yissum 29

Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 31

Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 32

Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 33

BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 34

Acquisition 36

Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 36

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd-Key Competitors 37

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd-Key Employees 38

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd-Locations And Subsidiaries 39

Head Office 39

Other Locations & Subsidiaries 39

Appendix 40

Methodology 40

About GlobalData 40

Contact Us 40

Disclaimer 40


List Of Figure

List of Figures

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Key Facts 2

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Deals By Therapy Area, 2012 to YTD 2018 9

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Atox Bio Raises USD30 Million in Financing 14

Avraham Pharma Raises up to USD4.5 Million Financing 16

Avraham Pharma Raises USD4.5 Million in Venture Financing 17

Avraham Pharma Raises USD 6 Million In Venture Financing 19

Integra Holdings Raises USD 7 Million In First Round Financing 20

Phytecs Enters into Agreement with Yissum Research Development 21

Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 22

Accurexa Enters into Agreement with Yissum Research Development 23

Yissum Research Development Expands Licensing Agreement with Israel Chemicals 24

BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25

Spherium Biomed Enters into Option Agreement with Yissum 26

Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 27

BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 28

Immune Pharma Enters into Licensing Agreement with Yissum 29

Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 31

Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 32

Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 33

BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 34

Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 36

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Competitors 37

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Key Employees 38

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Subsidiaries 39

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.